10 September 2026

CNS Therapeutics Xchange 2026 | CNS CRO

CNS Therapeutics Xchange 2026 | CNS CRO

CNS Therapeutics Xchange San Francisco 2026

Event: CNS Therapeutics Xchange San Francisco 2026

Dates: Thursday, September 10, 2026

Location: DoubleTree by Hilton San Francisco Airport Hotel, Burlingame, California

Sponsoring: Avance Clinical, an award-winning, Australian-based global CRO for biotechs with operations across the United States, Asia Pacific, China, and Europe and CNS Center of Excellence

Round table discussion: “Why CNS clinical trials fail: Addressing high screen failure rates, high attrition rates, and heterogeneity in neurological drug development”

Moderators: Dr. Francesco Bibbiani, MD, CPI, and Marty Kraut, PhD, PMP

Focus: Helping biotech sponsors advance CNS programs from preclinical strategy through early- and later-phase clinical development through our CNS Center of Excellence

About Avance Clinical’s CNS Center of Excellence

Avance Clinical is an award-winning, biotech-focused global CRO with a dedicated CNS Center of Excellence designed to support complex neuroscience programs.

CNS development places unique demands on clinical trial delivery, including difficult diagnosis pathways, high screen failure, patient heterogeneity, rater variability, caregiver burden, and retention challenges that can undermine timelines and data quality.

Avance Clinical’s CNS Center of Excellence is built to address those realities with specialist scientific, medical, and operational leadership.

Why CNS biotechs choose Avance Clinical’s CNS Center of Excellence

 

Trial Design Built for CNS Complexity

Avance Clinical supports CNS programs with design strategies tailored to heterogeneous patient populations, challenging endpoints, and the need to de-risk later development earlier. That includes practical attention to inclusion criteria, enrichment strategy, endpoint selection, visit schedules, and the operational burden that can shape both screen failure and attrition.

Specialist Science and Operational Depth

The CNS Center of Excellence is represented at this event by Dr. Francesco Bibbiani, Vice President & Therapeutic Area Head, Neuroscience, and Marty Kraut, Director of Operations, CNS Center of Excellence. Together, they reflect Avance Clinical’s integrated approach across medical, scientific, and operational planning for neuroscience studies.

One Team from Preclinical to Later Phase

Avance Clinical partners with biotechs from preclinical strategy through first-in-human, proof-of-concept, and later-phase clinical development. This continuity helps sponsors make better development decisions, maintain strategic alignment, and scale programs more efficiently across regions.

A Global Footprint for Biotech Growth

Avance Clinical is Australian-based and operates across the United States, Asia Pacific, China, and Europe, supporting biotech companies as programs expand beyond early development. That global model gives sponsors one partner with regionally informed execution and a biotech-centered operating approach.

Meet Avance Clinical at CNS Therapeutics Xchange San Francisco 2026

Meet Dr. Francesco Bibbiani, MD, CPI, Vice President & Therapeutic Area Head and Marty Kraut, PhD, PMP, Director of Operations, CNS Center of Excellence for a focused discussion on your next CNS program, whether you are planning:

  • Early development strategy for a neuroscience asset
  • First-in-human or proof-of-concept studies in CNS indications
  • Approaches to reduce screen failure and patient attrition in complex protocols
  • Later-phase development planning across global regions

Join Avance Clinical in Burlingame at this invitation-only event on September 10 for practical discussion around smarter, more resilient CNS clinical development.

Meet the team

Francesco-Bibbiani

Dr. Francesco Bibbiani, MD, CPI, Vice President & Therapeutic Area Head, Neuroscience, leads Avance Clinical’s CNS Center of Excellence with deep global experience in neurological and Rare Disease clinical development.

Marty Kraut

Marty Kraut, PhD, PMP, Director of Operations, CNS Center of Excellence, brings more than two decades of CNS-focused project management and clinical operations expertise across CRO environments.

Frequently Asked Questions

Yes. Avance Clinical is attending the event on Thursday, September 10, 2026, at the DoubleTree by Hilton San Francisco Airport Hotel in Burlingame, California.

It is Avance Clinical’s dedicated neuroscience capability designed to support complex CNS studies with specialist medical, scientific, and operational expertise.

Dr. Francesco Bibbiani, MD, CPI, and Marty Kraut, PhD, PMP, are the featured Avance Clinical leaders associated with the roundtable discussion.

Avance Clinical’s featured roundtable is “Why CNS clinical trials fail: Addressing high screen failure rates, high attrition rates, and heterogeneity in neurological drug development.”

Yes. Avance Clinical is Australian-based and has operations across the United States, Asia Pacific, China, and Europe.

Avance Clinical supports biotech sponsors from preclinical strategy through early- and later-phase clinical development for complex neuroscience programs.

Book a meeting

Book a meeting - Generic
Terms and conditions

Related Events